IP Library Granted Patent US 8,877,713
Granted Patent B2
US 8,877,713 · App. 13/935,675 · Granted Nov 4, 2014

Anti-aging peptides and cosmetic and/or pharmaceutical composition containing same

Inventors: Claude Dal Farra (Kerhonkson, NY); Nouha Domloge (Valbonne, FR); Jean-Marie Botto (Valbonne, FR)
Assignee: ISP Investments
A61K38/08C07K5/081A61Q19/08C07K14/4705A61K38/00A61K8/64
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,877,713
App. No.
13/935,675
Granted
Nov 4, 2014
Kind
B2
Abstract

Methods of restoring the circadian rhythm and resynchronizing the biological clock of cells are described. The methods include topically applying a topical composition comprising a cosmetically acceptable medium and an effective quantity of a peptide compound of general formula (I), R 1 -(AA) n -X 1 -Ser-Thr-Pro-X 2 -(AA) p -R 2 , to skin or skin appendages to be treated.

Claims (24)

1. A cosmetic method of restoring the circadian rhythm and resynchronizing the biological clock of skin cells, the method comprising:

topically applying, to skin or skin appendages to be treated, a topical composition comprising a cosmetically acceptable medium and an effective quantity of one or more peptide compounds

selected from the group consisting of:

(SEQ ID NO: 1)

Tyr-Val-Ser-Thr-Pro-Tyr-Asn-NH 2 ,

(SEQ ID NO: 2)

Val-Ser-Thr-Pro-Glu-NH 2 ,

(SEQ ID NO: 3)

Ser-Thr-Pro-NH 2 ,

(SEQ ID NO: 4)

Leu-His-Ser-Thr-Pro-NH 2 ,

(SEQ ID NO: 5)

Arg-His-Ser-Thr-Pro-Glu-NH 2 ,

and

(SEQ ID NO: 6)

His-Ser-Thr-Pro-Glu-NH 2 .

2. The method of claim 1 , wherein topically applying includes applying the peptide in an amount effective to activate cellular renewal, to stimulate cellular metabolism, to reduce the dysfunctions caused by jet lag or nightshift work, to treat the cutaneous signs of aging, or to reduce the signs of skin fatigue.

3. The method of claim 1 , further comprising solubilizing the peptide in one or more solvents selected from the group consisting of water, glycerol, ethanol, propylene glycol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclic polyols, petroleum jelly, a vegetable oil, and combinations thereof.

4. The method of claim 1 , wherein the effective amount of the peptide compound is at a concentration between approximately 0.0005 and 500 parts per million (ppm); wherein the effective amount is an amount to restore the circadian rhythm and resynchronize the biological clock of skin cells.

5. The method of claim 4 , wherein the effective amount of the peptide compound is at a concentration between 0.01 and 5 parts per million (ppm); wherein the effective amount is an amount to restore the circadian rhythm and resynchronize the biological clock of skin cells.

6. The method of claim 1 , wherein the topical composition further comprises at least one other active ingredient.

7. The method of claim 6 , wherein the other active ingredient is one or more of an anti-radical agent, an anti-oxidant agent, an agent stimulating the synthesis of dermal macromolecules, and an agent stimulating the energy metabolism.

8. The method of claim 1 , the composition is an oil-in-water or water-in-oil emulsion, a microemulsion, a cream, a salve, or an ointment.

9. The method of claim 1 , wherein the cosmetically acceptable medium forms an emulsion further comprising from 5 to 80% by weight of a fatty phase based on the total weight of the composition.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded Jun 8, 2017
From: ISP INVESTMENTS
To: ISP INVESTMENTS LLC
Reel/Frame 042740/0207 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2013
From: DAL FARRA, CLAUDE; DOMLOGE, NOUHA; BOTTO, JEAN-MARIE; IMBERT, ISABELLE
To: ISP INVESTMENTS
Reel/Frame 030825/0246 →
Priority Claims (1)
FR 09 00066 · Jan 9, 2009 · national
Continuity (2)
Division 13143754
Related Publication 20140045766A1 · Feb 13, 2014